<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6832525\results\search\disease\results.xml">
  <result pre="against this re-emerging pathogen which continues to cause devastating disease." exact="yellow fever" post="virus flavivirus entry factor global diversity yellow fever virus"/>
  <result pre="devastating disease. yellow fever virus flavivirus entry factor global diversity" exact="yellow fever" post="virus tropism animal models transmission and vector control vaccine"/>
  <result pre="described viral hemorrhagic fever (VHF) and its causative agent, the" exact="yellow fever" post="virus (YFV), is the prototypic member of the family"/>
  <result pre="infections, including dengue virus (DENV), West Nile virus (WNV), Japanese" exact="encephalitis" post="virus (JEV) and Zika virus (ZIKV) (Figure 1). Transmission"/>
  <result pre="cause a range of clinical outcomes, ranging from asymptomatic to" exact="encephalitis" post="(WNV, JEV and ZIKV) or fatal hemorrhagic fever (YFV"/>
  <result pre="abnormalities during this &quot;period of infection�? include elevated liver enzymes," exact="leukopenia" post="and proteinuria. A phase of improvement, lasting up to"/>
  <result pre="targeted at other members of the family Flaviviridae, most prominently" exact="hepatitis" post="C virus (HCV) and DENV. Ribavirin, a nucleoside analog,"/>
  <result pre="infection rates for WNV and YFV-17D to differing degrees, while" exact="herpes simplex" post="virus-1 (HSV-1) infection rates were unaffected [67]. Therefore, these"/>
  <result pre="also facilitates attachment for the related flaviviruses DENV [68] and" exact="tick-borne encephalitis" post="virus (TBEV) [69], as well as unrelated viruses, including"/>
  <result pre="facilitates attachment for the related flaviviruses DENV [68] and tick-borne" exact="encephalitis" post="virus (TBEV) [69], as well as unrelated viruses, including"/>
  <result pre="YFV was isolated from a Ghanaian patient suffering from mild" exact="yellow fever" post="and inoculated into rhesus macaques by direct blood/serum transfer"/>
  <result pre="mouse brain increased FNV’s neurotropism, leading to high levels of" exact="post-vaccinal encephalitis" post="in children. Consequently, the use of FNV was discontinued"/>
  <result pre="brain increased FNV’s neurotropism, leading to high levels of post-vaccinal" exact="encephalitis" post="in children. Consequently, the use of FNV was discontinued"/>
  <result pre="delivery platform for other experimental vaccines including HIV-1, Lassa fever," exact="malaria" post="and DENV [175,176,177,178,179,180]. After early successes in outbreak prevention"/>
  <result pre="to symptomatic HIV or the presence of thymus disorder, and" exact="hypersensitivity" post="to chicken eggs [161,187]. In addition, there are common"/>
  <result pre="[191]. The use of a live attenuated vaccine can prevent" exact="yellow fever," post="but vaccine-associated neurologic disease has been reported and is"/>
  <result pre="memory loss, problems with breathing, behavioral changes, seizures, viscerotropic disease," exact="encephalitis" post="and death can occur. In addition, the vaccine is"/>
  <result pre="epidemic in Asia remains daunting and YFV is the only" exact="infectious disease" post="where an international vaccination certificate is required [160]. However,"/>
  <result pre="certificates [198]. 6.5. Future Directions Yellow fever is a re-emerging" exact="infectious disease," post="as vector control and routine immunization strategies have dwindled"/>
  <result pre="this, the WHO has initiated a global strategy to eliminate" exact="yellow fever" post="epidemics (EYE) by 2026, focusing on management of global"/>
  <result pre="This approach has been applied to other RNA viruses, including" exact="chikungunya" post="(CHIKV) and TBEV [217,218]. In summary, in addition to"/>
  <result pre="[199]. Hence, novel manufacturing techniques to produce large quantities of" exact="yellow fever" post="vaccine at short notice are required which also eliminate"/>
  <result pre="from infected patients’ material, and these metagenomic approaches have revolutionized" exact="infectious disease" post="outbreak diagnostics and surveillance in recent years [225]. In"/>
  <result pre="likelihood of future arbovirus outbreaks, including YFV [243]. Mosquito population" exact="suppression" post="strategies which harness the power of genetic modification include"/>
  <result pre="carrying a dominant lethal transgene were released, resulting in the" exact="suppression" post="of wild mosquito numbers [244]. In a complementary approach"/>
  <result pre="Ae. albopictus from two test-release sites in China, combining population" exact="suppression" post="and population replacement strategies [245]. Male mosquitoes artificially infected"/>
  <result pre="with intrinsically expressed Loquacious and r2d2 to restore efficient siRNA" exact="suppression" post="of viral replication in the mosquito midgut [247]. Furthermore,"/>
  <result pre="future of eliminating YFV from endemic regions may involve the" exact="suppression" post="or replacement of wild-type mosquitos with modified insects which"/>
  <result pre="Yellow Fever in Angola, 2015–2016Emerg. Infect. Dis.2016221854185510.3201/eid2210.16081827536787 13.KraemerM.U.G.FariaN.R.ReinerR.C.GoldingN.NikolayB.StasseS.JohanssonM.A.SaljeH.FayeO.WintG.R.W.et al.Spread of" exact="yellow fever" post="virus outbreak in Angola and the Democratic Republic of"/>
  <result pre="feverScience201836184784810.1126/science.aau822530139914 16.FariaN.R.KraemerM.U.G.HillS.C.Goes de JesusJ.AguiarR.S.IaniF.C.M.XavierJ.QuickJ.Du PlessisL.DellicourS.et al.Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potentialScience201836189489910.1126/science.aat711530139911 17.DorigattiI.HamletA.AguasR.CattarinoL.CoriA.DonnellyC.A.GarskeT.ImaiN.FergusonN.M.International risk of yellow fever spread"/>
  <result pre="monitoring of yellow fever virus transmission potentialScience201836189489910.1126/science.aat711530139911 17.DorigattiI.HamletA.AguasR.CattarinoL.CoriA.DonnellyC.A.GarskeT.ImaiN.FergusonN.M.International risk of" exact="yellow fever" post="spread from the ongoing outbreak in Brazil, December 2016"/>
  <result pre="Surveill.20172210.2807/1560-7917.ES.2017.22.28.30572 18.MonathT.P.Yellow fever: An updateLancet Infect. Dis.20011112010.1016/S1473-3099(01)00016-011871403 19.RiceC.M.GrakouiA.GallerR.ChambersT.J.Transcription of infectious" exact="yellow fever" post="RNA from full-length cDNA templates produced by in vitro"/>
  <result pre="vitro ligationNew Biol.198912852962487295 20.HahnC.S.DalrympleJ.M.StraussJ.H.RiceC.M.Comparison of the virulent Asibi strain of" exact="yellow fever" post="virus with the 17D vaccine strain derived from itProc."/>
  <result pre="derived from itProc. Natl. Acad. Sci. USA1987842019202310.1073/pnas.84.7.20193470774 21.BredenbeekP.J.KooiE.A.LindenbachB.HuijkmanN.RiceC.M.SpaanW.J.M.A stable full-length" exact="yellow fever" post="virus cDNA clone and the role of conserved RNA"/>
  <result pre="RNA elements in flavivirus replicationJ. Gen. Virol.2003841261126810.1099/vir.0.18860-012692292 22.RiceC.M.LenchesE.M.EddyS.R.ShinS.J.SheetsR.L.StraussJ.H.Nucleotide sequence of" exact="yellow fever" post="virus: Implications for flavivirus gene expression and evolutionScience198522972673310.1126/science.40237074023707 23.McElroyK.L.TsetsarkinK.A.VanlandinghamD.L.HiggsS.Characterization"/>
  <result pre="and evolutionScience198522972673310.1126/science.40237074023707 23.McElroyK.L.TsetsarkinK.A.VanlandinghamD.L.HiggsS.Characterization of an infectious clone of the wild-type" exact="yellow fever" post="virus Asibi strain that is able to infect and"/>
  <result pre="applications: A historical perspectiveAntivir. Res.2015114678510.1016/j.antiviral.2014.12.00725512228 25.FuruseY.Analysis of research intensity on" exact="infectious disease" post="by disease burden reveals which infectious diseases are neglected"/>
  <result pre="12 August 2019) 29.QuaresmaJ.A.BarrosV.L.PagliariC.FernandesE.R.AndradeH.F.Jr.VasconcelosP.F.DuarteM.I.Hepatocyte lesions and cellular immune response in" exact="yellow fever" post="infectionTrans. R. Soc. Trop. Med. Hyg.200710116116810.1016/j.trstmh.2006.02.01916872652 30.BlakeL.E.Garcia-BlancoM.A.Human genetic variation"/>
  <result pre="infectionTrans. R. Soc. Trop. Med. Hyg.200710116116810.1016/j.trstmh.2006.02.01916872652 30.BlakeL.E.Garcia-BlancoM.A.Human genetic variation and" exact="yellow fever" post="mortality during 19th century U.S. epidemicsMBio20145e01253-1410.1128/mBio.01253-1424895309 31.TuboiS.H.CostaZ.G.da Costa VasconcelosP.F.HatchD.Clinical"/>
  <result pre="century U.S. epidemicsMBio20145e01253-1410.1128/mBio.01253-1424895309 31.TuboiS.H.CostaZ.G.da Costa VasconcelosP.F.HatchD.Clinical and epidemiological characteristics of" exact="yellow fever" post="in Brazil: Analysis of reported cases 1998-2002Trans. R. Soc."/>
  <result pre="targets the capsid proteinAntimicrob. Agents Chemother.201357152510.1128/AAC.01429-1223070172 40.PatkarC.G.LarsenM.OwstonM.SmithJ.L.KuhnR.J.Identification of inhibitors of" exact="yellow fever" post="virus replication using a replicon-based high-throughput assayAntimicrob. Agents Chemother.2009534103411410.1128/AAC.00074-0919651907"/>
  <result pre="by Specifically Targeting NS4B ProteinJ. Virol.201690107741078810.1128/JVI.01253-1627654301 42.PaccaC.C.SeverinoA.A.MondiniA.RahalP.D’Avila SG.CordeiroJ.A.NogueiraM.C.BronzoniR.V.NogueiraM.L.RNA interference inhibits" exact="yellow fever" post="virus replication in vitro and in vivoVirus Genes20093822423110.1007/s11262-009-0328-319169857 43.JulanderJ.G.Experimental"/>
  <result pre="46.PiersonT.C.KielianM.Flaviviruses: Braking the enteringCurr. Opin. Virol.2013331210.1016/j.coviro.2012.12.00123352692 47.PatkarC.G.JonesC.T.ChangY.-H.WarrierR.KuhnR.J.Functional requirements of the" exact="yellow fever" post="virus capsid proteinJ. Virol.2007816471648110.1128/JVI.02120-0617526891 48.Op de BeeckA.RouilléY.CaronM.DuvetS.DubuissonJ.The transmembrane domains"/>
  <result pre="BeeckA.RouilléY.CaronM.DuvetS.DubuissonJ.The transmembrane domains of the prM and E proteins of" exact="yellow fever" post="virus are endoplasmic reticulum localization signalsJ. Virol.200478125911260210.1128/JVI.78.22.12591-12602.200415507646 49.KielianM.Class II"/>
  <result pre="diversity in the flavivirus fusion peptideVirol. J.200852710.1186/1743-422X-5-2718275613 51.VolkD.E.MayF.J.GandhamS.H.A.AndersonA.von LindernJ.J.BeasleyD.W.C.BarrettA.D.T.GorensteinD.G.Structure of" exact="yellow fever" post="virus envelope protein domain IIIVirology2009394121810.1016/j.virol.2009.09.00119818466 52.RymanK.D.LedgerT.N.CampbellG.A.WatowichS.J.BarrettA.D.Mutation in a 17D-204"/>
  <result pre="17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of" exact="yellow fever" post="virus in miceVirology1998244596510.1006/viro.1998.90579581778 53.DaffisS.KontermannR.E.KorimbocusJ.ZellerH.KlenkH.-D.Ter MeulenJ.Antibody responses against wild-type yellow"/>
  <result pre="yellow fever virus in miceVirology1998244596510.1006/viro.1998.90579581778 53.DaffisS.KontermannR.E.KorimbocusJ.ZellerH.KlenkH.-D.Ter MeulenJ.Antibody responses against wild-type" exact="yellow fever" post="virus and the 17D vaccine strain: Characterization with human"/>
  <result pre="for exploratory research and analysisJ. Comput. Chem.2004251605161210.1002/jcc.2008415264254 56.ChenZ.LiuL.LvY.ZhangW.LiJ.ZhangY.DiT.ZhangS.LiuJ.LiJ.et al.A fatal" exact="yellow fever" post="virus infection in China: Description and lessonsEmerg. Microbes Infect.20165e6910.1038/emi.2016.8927406389"/>
  <result pre="68.GermiR.CranceJ.-M.GarinD.GuimetJ.Lortat-JacobH.RuigrokR.W.H.ZarskiJ.-P.DrouetE.Heparan sulfate-mediated binding of infectious dengue virus type 2 and" exact="yellow fever" post="virusVirology200229216216810.1006/viro.2001.123211878919 69.KroschewskiH.AllisonS.L.HeinzF.X.MandlC.W.Role of heparan sulfate for attachment and entry"/>
  <result pre="virusVirology200229216216810.1006/viro.2001.123211878919 69.KroschewskiH.AllisonS.L.HeinzF.X.MandlC.W.Role of heparan sulfate for attachment and entry of" exact="tick-borne encephalitis" post="virusVirology20033089210010.1016/S0042-6822(02)00097-112706093 70.ShuklaD.LiuJ.BlaiklockP.ShworakN.W.BaiX.EskoJ.D.CohenG.H.EisenbergR.J.RosenbergR.D.SpearP.G.A novel role for 3-O-sulfated heparan sulfate in"/>
  <result pre="69.KroschewskiH.AllisonS.L.HeinzF.X.MandlC.W.Role of heparan sulfate for attachment and entry of tick-borne" exact="encephalitis" post="virusVirology20033089210010.1016/S0042-6822(02)00097-112706093 70.ShuklaD.LiuJ.BlaiklockP.ShworakN.W.BaiX.EskoJ.D.CohenG.H.EisenbergR.J.RosenbergR.D.SpearP.G.A novel role for 3-O-sulfated heparan sulfate in"/>
  <result pre="encephalitis virusVirology20033089210010.1016/S0042-6822(02)00097-112706093 70.ShuklaD.LiuJ.BlaiklockP.ShworakN.W.BaiX.EskoJ.D.CohenG.H.EisenbergR.J.RosenbergR.D.SpearP.G.A novel role for 3-O-sulfated heparan sulfate in" exact="herpes simplex" post="virus 1 entryCell199999132210.1016/S0092-8674(00)80058-610520990 71.PatelM.YanagishitaM.RoderiquezG.Bou-HabibD.C.OraveczT.HascallV.C.NorcrossM.A.Cell-surface heparan sulfate proteoglycan mediates HIV-1"/>
  <result pre="and Its Infectious Molecular CloneJ. Virol.2001751091210.1128/JVI.75.22.10912-10922.200111602731 81.MaillyL.XiaoF.LupbergerJ.WilsonG.K.AubertP.DuongF.H.T.CalabreseD.LeboeufC.FofanaI.ThumannC.et al.Clearance of persistent" exact="hepatitis" post="C virus infection in humanized mice using a claudin-1-targeting"/>
  <result pre="That Promote Early Viral Protein AccumulationJ. Virol.20179110.1128/JVI.01706-1627974556 83.ChambersT.J.GrakouiA.RiceC.M.Processing of the" exact="yellow fever" post="virus nonstructural polyprotein: A catalytically active NS3 proteinase domain"/>
  <result pre="94.ChambersT.J.WeirR.C.GrakouiA.McCourtD.W.BazanJ.F.FletterickR.J.RiceC.M.Evidence that the N-terminal domain of nonstructural protein NS3 from" exact="yellow fever" post="virus is a serine protease responsible for site-specific cleavages"/>
  <result pre="linked to differential phosphorylation of NS5J. Biol. Chem.1995270191001910610.1074/jbc.270.32.191007642575 99.BhattacharyaD.HooverS.FalkS.P.WeisblumB.VestlingM.StrikerR.Phosphorylation of" exact="yellow fever" post="virus NS5 alters methyltransferase activityVirology200838027628410.1016/j.virol.2008.07.01318757072 100.KümmererB.M.RiceC.M.Mutations in the yellow"/>
  <result pre="yellow fever virus NS5 alters methyltransferase activityVirology200838027628410.1016/j.virol.2008.07.01318757072 100.KümmererB.M.RiceC.M.Mutations in the" exact="yellow fever" post="virus nonstructural protein NS2A selectively block production of infectious"/>
  <result pre="by West Nile virus non-structural protein 4BPLoS ONE20149e8404010.1371/journal.pone.008404024465392 106.DesprèsP.GirardM.BouloyM.Characterization of" exact="yellow fever" post="virus proteins E and NS1 expressed in Vero and"/>
  <result pre="protein prM is necessary for infection of BHK-21 cells by" exact="tick-borne encephalitis" post="virusJ. Gen. Virol.20038418319110.1099/vir.0.18723-012533715 112.StadlerK.AllisonS.L.SchalichJ.HeinzF.X.Proteolytic activation of tick-borne encephalitis virus"/>
  <result pre="prM is necessary for infection of BHK-21 cells by tick-borne" exact="encephalitis" post="virusJ. Gen. Virol.20038418319110.1099/vir.0.18723-012533715 112.StadlerK.AllisonS.L.SchalichJ.HeinzF.X.Proteolytic activation of tick-borne encephalitis virus"/>
  <result pre="cells by tick-borne encephalitis virusJ. Gen. Virol.20038418319110.1099/vir.0.18723-012533715 112.StadlerK.AllisonS.L.SchalichJ.HeinzF.X.Proteolytic activation of" exact="tick-borne encephalitis" post="virus by furinJ. Virol.199771847584819343204 113.QuaresmaJ.A.S.BarrosV.L.R.S.PagliariC.FernandesE.R.GuedesF.TakakuraC.F.H.AndradeH.F.VasconcelosP.F.C.DuarteM.I.S.Revisiting the liver in human"/>
  <result pre="by tick-borne encephalitis virusJ. Gen. Virol.20038418319110.1099/vir.0.18723-012533715 112.StadlerK.AllisonS.L.SchalichJ.HeinzF.X.Proteolytic activation of tick-borne" exact="encephalitis" post="virus by furinJ. Virol.199771847584819343204 113.QuaresmaJ.A.S.BarrosV.L.R.S.PagliariC.FernandesE.R.GuedesF.TakakuraC.F.H.AndradeH.F.VasconcelosP.F.C.DuarteM.I.S.Revisiting the liver in human"/>
  <result pre="synthesis of tumor necrosis factor-alpha in healthy humans after live" exact="yellow fever" post="vaccinationJ. Infect. Dis.1998377477810.1086/5178069498462 116.QuerecT.BennounaS.AlkanS.LaouarY.GordenK.FlavellR.AkiraS.AhmedR.PulendranB.Yellow fever vaccine YF-17D activates multiple"/>
  <result pre="secrete interferonsSci. Rep.201881088910.1038/s41598-018-29235-730022130 118.Laurent-RolleM.MorrisonJ.RajsbaumR.MacleodJ.M.L.PisanelliG.PhamA.AyllonJ.MiorinL.MartinezC.tenOeverB.R.et al.The interferon signaling antagonist function of" exact="yellow fever" post="virus NS5 protein is activated by type I interferonCell"/>
  <result pre="exerts a critical early restriction on replication and dissemination of" exact="yellow fever" post="virus vaccine strain 17D-204NPJ Vaccines20183510.1038/s41541-017-0039-z29387474 122.DouamF.HrebikovaG.AlbrechtY.E.S.SellauJ.SharonY.DingQ.PlossA.Single-cell tracking of flavivirus"/>
  <result pre="in Resisting FlavivirusJ. Immunol. Res.20182018610658210.1155/2018/610658229888293 128.OlagnierD.ScholteF.E.M.ChiangC.AlbulescuI.C.NicholsC.HeZ.LinR.SnijderE.J.van HemertM.J.HiscottJ.Inhibition of dengue and" exact="chikungunya" post="virus infections by RIG-I-mediated type I interferon-independent stimulation of"/>
  <result pre="IPS-1J. Virol.20088260961610.1128/JVI.01305-0717977974 130.NazmiA.MukhopadhyayR.DuttaK.BasuA.STING mediates neuronal innate immune response following Japanese" exact="encephalitis" post="virus infectionSci. Rep.2012234710.1038/srep0034722470840 131.IshikawaH.BarberG.N.STING is an endoplasmic reticulum adaptor"/>
  <result pre="reservoirs for flaviviruses (yellow fever, dengue 2 and St Louis" exact="encephalitis" post="viruses) in French GuianaTrans. R. Soc. Trop. Med. Hyg.20049840941210.1016/j.trstmh.2003.12.00315138077"/>
  <result pre="French GuianaTrans. R. Soc. Trop. Med. Hyg.20049840941210.1016/j.trstmh.2003.12.00315138077 144.JulanderJ.G.Animal models of" exact="yellow fever" post="and their application in clinical researchCurr. Opin. Virol.201618646910.1016/j.coviro.2016.03.01027093699 145.WilsonE.M.BialJ.TarlowB.BialG.JensenB.GreinerD.L.BrehmM.A.GrompeM.Extensive"/>
  <result pre="human hepatocytesPLoS ONE201510e011982010.1371/journal.pone.011982025782010 147.BarrettA.D.GouldE.A.Comparison of neurovirulence of different strains of" exact="yellow fever" post="virus in miceJ. Gen. Virol.19866763163710.1099/0022-1317-67-4-6313958694 148.AlmeidaM.A.B.CardosoJ.d.C.Dos SantosE.da FonsecaD.F.CruzL.L.FaracoF.J.C.BerciniM.A.VettorelloK.C.PortoM.A.MohrdieckR.et al.Surveillance"/>
  <result pre="MosquitoesViruses201573741376710.3390/v707279526184281 151.DanetL.BeauclairG.BerthetM.MoratorioG.GraciasS.TangyF.ChoumetV.JouvenetN.Midgut barriers prevent the replication and dissemination of the" exact="yellow fever" post="vaccine in Aedes aegyptiPLoS Negl. Trop. Dis.201957721310.1371/journal.pntd.0007299 152.EricksonA.K.PfeifferJ.K.Dynamic viral"/>
  <result pre="Negl. Trop. Dis.201957721310.1371/journal.pntd.0007299 152.EricksonA.K.PfeifferJ.K.Dynamic viral dissemination in mice infected with" exact="yellow fever" post="virus strain 17DJ. Virol.201387123921239710.1128/JVI.02149-1324027319 153.DouamF.Soto AlbrechtY.E.HrebikovaG.SadiminE.DavidsonC.KotenkoS.V.PlossA.Type III Interferon-Mediated Signaling"/>
  <result pre="VivoMBio20178e00819-1710.1128/mBio.00819-1728811340 154.MeierK.C.GardnerC.L.KhoretonenkoM.V.KlimstraW.B.RymanK.D.A mouse model for studying viscerotropic disease caused by" exact="yellow fever" post="virus infectionPLoS Pathog.20095e100061410.1371/journal.ppat.100061419816561 155.MiorinL.Laurent-RolleM.PisanelliG.CoP.H.AlbrechtR.A.Garcia-SastreA.MorrisonJ.Host-Specific NS5 Ubiquitination Determines Yellow Fever"/>
  <result pre="TropismJ. Virol.20199310.1128/JVI.00151-1931043530 156.MinorP.The polio endgameHum. Vaccin. Immunother.2014102106210810.4161/21645515.2014.98111525608050 157.StokesA.BauerJ.H.HudsonN.P.The transmission of" exact="yellow fever" post="to Macacus rhesusRev. Med. Virol.20011114114810.1002/rmv.31111376477 158.RoukensA.H.VisserL.G.Yellow fever vaccine: Past,"/>
  <result pre="Opin. Biol. Ther.200881787179510.1517/14712598.8.11.178718847312 159.FerreiraC.C.Campi-AzevedoA.C.Peruhype-MagalhaesV.Costa-PereiraC.AlbuquerqueC.P.MunizL.F.Yokoy de SouzaT.OliveiraA.C.V.Martins-FilhoO.A.da MotaL.M.H.The 17D-204 and 17DD" exact="yellow fever" post="vaccines: An overview of major similarities and subtle differencesExpert"/>
  <result pre="for Studies on Yellow Fever VaccinesDuration of post-vaccination immunity against" exact="yellow fever" post="in adultsVaccine2014324977498410.1016/j.vaccine.2014.07.02125090646 164.GotuzzoE.YactayoS.CórdovaE.Efficacy and duration of immunity after yellow"/>
  <result pre="yellow fever in adultsVaccine2014324977498410.1016/j.vaccine.2014.07.02125090646 164.GotuzzoE.YactayoS.CórdovaE.Efficacy and duration of immunity after" exact="yellow fever" post="vaccination: Systematic review on the need for a booster"/>
  <result pre="humoral and cellular parameters of immune activation after vaccination with" exact="yellow fever" post="virus strain 17D: A model of human flavivirus infectionJ."/>
  <result pre="T-Cell Responses after VaccinationPLoS ONE201611e014987110.1371/journal.pone.014987126977808 167.NiedrigM.LademannM.EmmerichP.LafrenzM.Assessment of IgG antibodies against" exact="yellow fever" post="virus after vaccination with 17D by different assays: Neutralization"/>
  <result pre="Med. Biol.2007590435310.1007/978-0-387-34814-8_317191376 170.QuerecT.D.AkondyR.S.LeeE.K.CaoW.NakayaH.I.TeuwenD.PiraniA.GernertK.DengJ.MarzolfB.et al.Systems biology approach predicts immunogenicity of the" exact="yellow fever" post="vaccine in humansNat. Immunol.20091011612510.1038/ni.168819029902 171.KasturiS.P.SkountzouI.AlbrechtR.A.KoutsonanosD.HuaT.NakayaH.I.RavindranR.StewartS.AlamM.KwissaM.et al.Programming the magnitude and"/>
  <result pre="172.Da Costa NevesP.C.MatosD.C.d.S.MarcovistzR.GallerR.TLR expression and NK cell activation after human" exact="yellow fever" post="vaccinationVaccine2009275543554910.1016/j.vaccine.2009.07.02819647065 173.GaucherD.TherrienR.KettafN.AngermannB.R.BoucherG.Filali-MouhimA.MoserJ.M.MehtaR.S.DrakeD.R.CastroE.et al.Yellow fever vaccine induces integrated multilineage and"/>
  <result pre="vaccine vector for microbial CTL epitopes: Protection in a rodent" exact="malaria" post="modelJ. Exp. Med.200520120120910.1084/jem.2004152615657290 176.BredenbeekP.J.MolenkampR.SpaanW.J.DeubelV.MarianneauP.SalvatoM.S.MoshkoffD.ZapataJ.TikhonovI.PattersonJ.et al.A recombinant Yellow Fever 17D"/>
  <result pre="Yellow Fever 17D vaccine expressing Lassa virus glycoproteinsVirology200634529930410.1016/j.virol.2005.12.00116412488 177.FrancoD.LiW.QingF.StoyanovC.T.MoranT.RiceC.M.HoD.D.Evaluation of" exact="yellow fever" post="virus 17D strain as a new vector for HIV-1"/>
  <result pre="YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese" exact="encephalitis" post="virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 179.StoyanovC.T.BoscardinS.B.DeroubaixS.Barba-SpaethG.FrancoD.NussenzweigR.S.NussenzweigM.RiceC.M.Immunogenicity and protective efficacy of a recombinant yellow"/>
  <result pre="Japanese encephalitis virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 179.StoyanovC.T.BoscardinS.B.DeroubaixS.Barba-SpaethG.FrancoD.NussenzweigR.S.NussenzweigM.RiceC.M.Immunogenicity and protective efficacy of a recombinant" exact="yellow fever" post="vaccine against the murine malarial parasite Plasmodium yoeliiVaccine2010284644465210.1016/j.vaccine.2010.04.07120451637 180.BonaldoM.C.SequeiraP.C.GallerR.The"/>
  <result pre="fever vaccine against the murine malarial parasite Plasmodium yoeliiVaccine2010284644465210.1016/j.vaccine.2010.04.07120451637 180.BonaldoM.C.SequeiraP.C.GallerR.The" exact="yellow fever" post="17D virus as a platform for new live attenuated"/>
  <result pre="attenuated vaccinesHum. Vaccin. Immunother.2014101256126510.4161/hv.2811724553128 181.BeckA.S.BarrettA.D.T.Current status and future prospects of" exact="yellow fever" post="vaccinesExpert Rev. Vaccines2015141479149210.1586/14760584.2015.108343026366673 182.OtshudiemaJ.O.NdakalaN.G.MawandaE.-T.K.TshapendaG.P.KimfutaJ.M.NsibuL.-R.N.GueyeA.S.DeeJ.PhilenR.M.GieseC.et al.Yellow Fever Outbreak - Kongo"/>
  <result pre="challenges for immunisationMem. Inst. Oswaldo Cruz2018113e18027810.1590/0074-0276018027830427974 187.JonkerE.F.VisserL.G.RoukensA.H.Advances and controversies in" exact="yellow fever" post="vaccinationTher. Adv. Vaccines2013114415210.1177/205101361349895424757521 188.KartogluU.MilstienJ.Tools and approaches to ensure quality"/>
  <result pre="al.Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated" exact="yellow fever" post="infectionNat. Med.2019251218122410.1038/s41591-019-0510-731308506 192.McMahonA.W.EidexR.B.MarfinA.A.RussellM.SejvarJ.J.MarkoffL.HayesE.B.ChenR.T.BallR.BraunM.M.et al.Neurologic disease associated with 17D-204 yellow"/>
  <result pre="yellow fever infectionNat. Med.2019251218122410.1038/s41591-019-0510-731308506 192.McMahonA.W.EidexR.B.MarfinA.A.RussellM.SejvarJ.J.MarkoffL.HayesE.B.ChenR.T.BallR.BraunM.M.et al.Neurologic disease associated with 17D-204" exact="yellow fever" post="vaccination: A report of 15 casesVaccine2007251727173410.1016/j.vaccine.2006.11.02717240001 193.ThomasR.E.LorenzettiD.L.SpraginsW.JacksonD.WilliamsonT.Active and passive"/>
  <result pre="A report of 15 casesVaccine2007251727173410.1016/j.vaccine.2006.11.02717240001 193.ThomasR.E.LorenzettiD.L.SpraginsW.JacksonD.WilliamsonT.Active and passive surveillance of" exact="yellow fever" post="vaccine 17D or 17DD-associated serious adverse events: Systematic reviewVaccine2011294544455510.1016/j.vaccine.2011.04.05521549787"/>
  <result pre="reviewRev. Panam Salud Publica201842e7510.26633/RPSP.2018.7531093103 195.BelsherJ.L.GayP.BrintonM.DellaVallaJ.RidenourR.LanciottiR.PerelyginA.ZakiS.PaddockC.QuerecT.et al.Fatal multiorgan failure due to" exact="yellow fever" post="vaccine-associated viscerotropic diseaseVaccine2007258480848510.1016/j.vaccine.2007.08.06118023511 196.Conesa-BotellaA.ColebundersR.Response to &quot;Case of yellow fever"/>
  <result pre="to yellow fever vaccine-associated viscerotropic diseaseVaccine2007258480848510.1016/j.vaccine.2007.08.06118023511 196.Conesa-BotellaA.ColebundersR.Response to &quot;Case of" exact="yellow fever" post="vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune"/>
  <result pre="IFNAR1 deficiency in otherwise healthy patients with adverse reaction to" exact="measles" post="and yellow fever live vaccinesJ. Exp. Med.201910.1084/jem.20182295 198.CalisherC.H.WoodallJ.P.Yellow Fever-More"/>
  <result pre="in otherwise healthy patients with adverse reaction to measles and" exact="yellow fever" post="live vaccinesJ. Exp. Med.201910.1084/jem.20182295 198.CalisherC.H.WoodallJ.P.Yellow Fever-More a Policy and"/>
  <result pre="Yellow Fever VaccinationAm. J. Trop. Med. Hyg.2016951435143910.4269/ajtmh.16-040127928091 201.ZhaoS.StoneL.GaoD.HeD.Modelling the large-scale" exact="yellow fever" post="outbreak in Luanda, Angola, and the impact of vaccinationPLoS"/>
  <result pre="Trop. Dis.201812e000615810.1371/journal.pntd.000615829338001 202.HamletA.JeanK.YactayoS.BenzlerJ.CibrelusL.FergusonN.GarskeT.POLICI: A web application for visualising and extracting" exact="yellow fever" post="vaccination coverage in AfricaVaccine2019371384138810.1016/j.vaccine.2019.01.07430770224 203.SchaferB.HolzerG.W.JoachimsthalerA.CoulibalyS.SchwendingerM.CroweB.A.KreilT.R.BarrettP.N.FalknerF.G.Pre-clinical efficacy and safety of"/>
  <result pre="204.MacielM.Jr.Cruz FdaS.CordeiroM.T.da MottaM.A.CassemiroK.M.Maia RdeC.de FigueiredoR.C.GallerR.Freire MdaS.AugustJ.T.et al.A DNA vaccine against" exact="yellow fever" post="virus: Development and evaluationPLoS Negl. Trop. Dis.20159e000369310.1371/journal.pntd.000369325875109 205.TotteyS.ShojiY.JonesR.M.ChichesterJ.A.GreenB.J.MusiychukK.SiH.MancevaS.D.RheeA.ShamloulM.et al.Plant-Produced"/>
  <result pre="Protection Conferred by the VSV-Vectored Ebola Virus VaccineMBio20191010.1128/mBio.01597-19 209.MonathT.P.LeeC.K.JulanderJ.G.BrownA.BeasleyD.W.WattsD.M.HaymanE.GuertinP.MakowieckiJ.CrowellJ.et al.Inactivated" exact="yellow fever" post="17D vaccine: Development and nonclinical safety, immunogenicity and protective"/>
  <result pre="vaccination: Past, present and futureFuture Microbiol.20151079180810.2217/fmb.15.1925824845 215.KlittingR.RizikiT.MoureauG.PiorkowskiG.GouldE.A.de LamballerieX.Exploratory re-encoding of" exact="yellow fever" post="virus genome: New insights for the design of live-attenuated"/>
  <result pre="in primate and mosquito cellsPLoS Pathog.20139e100317210.1371/journal.ppat.100317223436995 218.de FabritusL.NougairedeA.AubryF.GouldE.A.de LamballerieX.Attenuation of" exact="tick-borne encephalitis" post="virus using large-scale random codon re-encodingPLoS Pathog.201511e100473810.1371/journal.ppat.100473825734338 219.CarringtonC.V.F.AugusteA.J.Evolutionary and"/>
  <result pre="primate and mosquito cellsPLoS Pathog.20139e100317210.1371/journal.ppat.100317223436995 218.de FabritusL.NougairedeA.AubryF.GouldE.A.de LamballerieX.Attenuation of tick-borne" exact="encephalitis" post="virus using large-scale random codon re-encodingPLoS Pathog.201511e100473810.1371/journal.ppat.100473825734338 219.CarringtonC.V.F.AugusteA.J.Evolutionary and"/>
  <result pre="219.CarringtonC.V.F.AugusteA.J.Evolutionary and ecological factors underlying the tempo and distribution of" exact="yellow fever" post="virus activityInfect. Genet. Evol.20131319821010.1016/j.meegid.2012.08.01522981999 220.LemoineF.CorreiaD.LefortV.Doppelt-AzeroualO.MareuilF.Cohen-BoulakiaS.GascuelO.NGPhylogeny.fr: New generation phylogenetic services"/>
  <result pre="frontier of genome engineering with CRISPR-Cas9Science2014346125809610.1126/science.125809625430774 223.PugachevK.V.GuirakhooF.OcranS.W.MitchellF.ParsonsM.PenalC.GirakhooS.PougatchevaS.O.ArroyoJ.TrentD.W.et al.High fidelity of" exact="yellow fever" post="virus RNA polymeraseJ. Virol.2004781032103810.1128/JVI.78.2.1032-1038.200414694136 224.VlachakisD.KoumandouV.L.KossidaS.A holistic evolutionary and structural"/>
  <result pre="Negl. Trop. Dis.201711e000607510.1371/journal.pntd.000607529155823 227.McMullanL.K.FraceM.SammonsS.A.ShoemakerT.BalinandiS.WamalaJ.F.LutwamaJ.J.DowningR.G.StroeherU.MacNeilA.et al.Using next generation sequencing to identify" exact="yellow fever" post="virus in UgandaVirology20124221510.1016/j.virol.2011.08.02421962764 228.QuickJ.LomanN.J.DuraffourS.SimpsonJ.T.SeveriE.CowleyL.BoreJ.A.KoundounoR.DudasG.MikhailA.et al.Real-time, portable genome sequencing for"/>
  <result pre="epidemicInt. J. Infect. Dis.2016489810310.1016/j.ijid.2016.04.02527156836 233.ChenC.JiangD.NiM.LiJ.ChenZ.LiuJ.YeH.WongG.LiW.ZhangY.et al.Phylogenomic analysis unravels evolution of" exact="yellow fever" post="virus within hostsPLoS Negl. Trop. Dis.201812e000673810.1371/journal.pntd.000673830188905 234.SallA.A.FayeO.DialloM.FirthC.KitchenA.HolmesE.C.Yellow fever virus"/>
  <result pre="Arbovirus Vertical Transmission in MosquitoesPLoS Pathog.201612e100554810.1371/journal.ppat.100554827171170 237.DialloM.ThonnonJ.FontenilleD.Vertical transmission of the" exact="yellow fever" post="virus by Aedes aegypti (Diptera, Culicidae): Dynamics of infection"/>
  <result pre="Trop. Med. Hyg.20006215115610.4269/ajtmh.2000.62.15110761742 238.AmraouiF.VazeilleM.FaillouxA.B.French Aedes albopictus are able to transmit" exact="yellow fever" post="virusEuro Surveill.20162110.2807/1560-7917.ES.2016.21.39.30361 239.KraemerM.U.G.ReinerR.C.Jr.BradyO.J.MessinaJ.P.GilbertM.PigottD.M.YiD.JohnsonK.EarlL.MarczakL.B.et al.Past and future spread of the"/>
  <result pre="albopictusNat. Microbiol.2019485486310.1038/s41564-019-0376-y30833735 240.HamrickP.N.AldighieriS.MachadoG.LeonelD.G.VilcaL.M.UrionaS.SchneiderM.C.Geographic patterns and environmental factors associated with human" exact="yellow fever" post="presence in the AmericasPLoS Negl. Trop. Dis.201711e000589710.1371/journal.pntd.000589728886023 241.KupferschmidtK.After 40"/>
  <result pre="vector-borne diseases by releasing modified mosquitoesNat. Rev. Microbiol.20181650851810.1038/s41579-018-0025-029777177 244.HarrisA.F.McKemeyA.R.NimmoD.CurtisZ.BlackI.MorganS.A.OviedoM.N.LacroixR.NaishN.MorrisonN.I.et al.Successful" exact="suppression" post="of a field mosquito population by sustained release of"/>
 </snippets>
</snippetsTree>
